An imported H9N2 avian influenza infection in Italy is a surveillance milestone, not a community outbreak signal. On April 10, 2026, the WHO reported that Italy notified a laboratory-confirmed A(H9N2) case in an adult male who had returned from Senegal.
WHO called it the first imported human H9N2 avian influenza case reported in the European Region. Based on available information, the agency assessed risk to the general population as low and said characterized H9N2 viruses have not shown sustained human-to-human transmission.
How the H9N2 avian influenza case unfolded
The patient had spent more than six months in Senegal and traveled to Italy in mid-March. He sought emergency care with fever and a persistent cough. A bronchoalveolar lavage specimen tested positive for Mycobacterium tuberculosis and an un-subtypeable influenza A virus. He was isolated with airborne precautions and treated with antitubercular medicine and oseltamivir. By April 9, his condition was stable and improving.
Regional testing identified A(H9) on March 20, and next-generation sequencing confirmed A(H9N2) on March 21. Genetic findings pointed to an avian source linked to Senegal, with similarity to poultry strains previously identified there. Investigators found no known poultry exposure and no contact with symptomatic people. Contacts in Senegal were asymptomatic; traced contacts in Italy tested negative, completed monitoring, and received preventive oseltamivir.
What WHO says about risk and response
Most reported human H9N2 infections have followed poultry or contaminated-environment exposure, often with mild illness. The virus remains enzootic in poultry in parts of Africa and Asia. WHO advised against travel or trade restrictions based on current information and urged standard precautions around live bird markets and sick poultry.
For Health readers, the dual diagnosis of tuberculosis and H9N2 avian influenza also shows why hospitals need broad respiratory workups for returning travelers, not single-pathogen assumptions.
Axo analysis: import detection is the system working
The Axo takeaway is verification and context. A first regional import report can sound alarming; the epidemiology still points to spillover risk without community spread. Contact tracing, isolation, and genetic matching to Senegal poultry viruses are the operational story.
What to watch next is any additional European cases, clearer exposure findings from Senegal, and whether genetic markers of mammalian adaptation appear. This summary is not medical advice.